Selected research
Market Structure
Global Exosome Medical Technology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Exosome Medical Technology market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Exosome Medical Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Exosome Medical Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Exosome Medical Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Exosome Medical Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Exosome Medical Technology include Aegle Therapeutics, Anjarium Biosciences, Aruna Biomedical, Carmine Therapeutics, Evox Therapeutics, Exosome Diagnostics, Inc., ExonanoRNA LLC.,, Codiak BioSciences and Esperite Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Exosome Medical Technology market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Exosome Medical Technology and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Exosome Medical Technology revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Exosome Medical Technology market size, projected growth trends, production technologies, key applications, and end-use industries.
Exosome Medical Technology Segment by Company
Aegle Therapeutics
Anjarium Biosciences
Aruna Biomedical
Carmine Therapeutics
Evox Therapeutics
Exosome Diagnostics, Inc.
ExonanoRNA LLC.,
Codiak BioSciences
Esperite Group
Tavec Pharmaceuticals
Exosome Medical Technology Segment by Type
Transmission Electron Microscopy
Nanoparticle Tracking Analysis
Western Blot Molecular Marker Detection
Exosome Medical Technology Segment by Application
Healthcare Providers
Pharmaceutical & Biotechnology Companies
Others
Exosome Medical Technology Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exosome Medical Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Exosome Medical Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exosome Medical Technology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Exosome Medical Technology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Exosome Medical Technology industry.
Chapter 3: Detailed analysis of Exosome Medical Technology companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Exosome Medical Technologyrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Transmission Electron Microscopy
- Nanoparticle Tracking Analysis
- Western Blot Molecular Marker Detection
Applications
- Healthcare Providers
- Pharmaceutical & Biotechnology Companies
- Others
Companies covered
- Aegle Therapeutics
- Anjarium Biosciences
- Aruna Biomedical
- Carmine Therapeutics
- Evox Therapeutics
- Exosome Diagnostics, Inc.
- ExonanoRNA LLC.,
- Codiak BioSciences
- Esperite Group
- Tavec Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Exosome Medical Technology Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Transmission Electron Microscopy
- 1.2.3 Nanoparticle Tracking Analysis
- 1.2.4 Western Blot Molecular Marker Detection
- 1.3 Market Analysis by Application
- 1.3.1 Global Exosome Medical Technology Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Healthcare Providers
- 1.3.3 Pharmaceutical & Biotechnology Companies
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Exosome Medical Technology Growth Trends by Region
- 1.5.1 Global Exosome Medical Technology Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Exosome Medical Technology Market Size by Region (2021-2026)
- 1.5.3 Exosome Medical Technology Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Exosome Medical Technology Market Dynamics
- 2.1 Exosome Medical Technology Industry Trends
- 2.2 Exosome Medical Technology Industry Drivers
- 2.3 Exosome Medical Technology Industry Opportunities and Challenges
- 2.4 Exosome Medical Technology Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Exosome Medical Technology Revenue by Company (2021-2026)
- 3.2 Global Exosome Medical Technology Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Exosome Medical Technology Key Company Head office and Area Served
- 3.4 Global Exosome Medical Technology Company, Product Type & Application
- 3.5 Global Exosome Medical Technology Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Exosome Medical Technology Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Exosome Medical Technology Players Market Share by Revenue in 2025
- 3.6.3 2025 Exosome Medical Technology Tier 1, Tier 2, and Tier 3
4 Exosome Medical Technology Market by Type
- 4.1 Global Exosome Medical Technology Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Exosome Medical Technology Market Size by Type (2021-2032)
- 4.3 Global Exosome Medical Technology Market Size Share by Type (2021-2032)
5 Exosome Medical Technology Market by Application
- 5.1 Global Exosome Medical Technology Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Exosome Medical Technology Market Size by Application (2021-2032)
- 5.3 Global Exosome Medical Technology Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Aegle Therapeutics
- 6.1.1 Aegle Therapeutics Company Information
- 6.1.2 Aegle Therapeutics Business Overview
- 6.1.3 Aegle Therapeutics Exosome Medical Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Aegle Therapeutics Exosome Medical Technology Product Portfolio
- 6.1.5 Aegle Therapeutics Recent Developments
- 6.2 Anjarium Biosciences
- 6.2.1 Anjarium Biosciences Company Information
- 6.2.2 Anjarium Biosciences Business Overview
- 6.2.3 Anjarium Biosciences Exosome Medical Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Anjarium Biosciences Exosome Medical Technology Product Portfolio
- 6.2.5 Anjarium Biosciences Recent Developments
- 6.3 Aruna Biomedical
- 6.3.1 Aruna Biomedical Company Information
- 6.3.2 Aruna Biomedical Business Overview
- 6.3.3 Aruna Biomedical Exosome Medical Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Aruna Biomedical Exosome Medical Technology Product Portfolio
- 6.3.5 Aruna Biomedical Recent Developments
- 6.4 Carmine Therapeutics
- 6.4.1 Carmine Therapeutics Company Information
- 6.4.2 Carmine Therapeutics Business Overview
- 6.4.3 Carmine Therapeutics Exosome Medical Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Carmine Therapeutics Exosome Medical Technology Product Portfolio
- 6.4.5 Carmine Therapeutics Recent Developments
- 6.5 Evox Therapeutics
- 6.5.1 Evox Therapeutics Company Information
- 6.5.2 Evox Therapeutics Business Overview
- 6.5.3 Evox Therapeutics Exosome Medical Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Evox Therapeutics Exosome Medical Technology Product Portfolio
- 6.5.5 Evox Therapeutics Recent Developments
- 6.6 Exosome Diagnostics, Inc.
- 6.6.1 Exosome Diagnostics, Inc. Company Information
- 6.6.2 Exosome Diagnostics, Inc. Business Overview
- 6.6.3 Exosome Diagnostics, Inc. Exosome Medical Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Exosome Diagnostics, Inc. Exosome Medical Technology Product Portfolio
- 6.6.5 Exosome Diagnostics, Inc. Recent Developments
- 6.7 ExonanoRNA LLC.,
- 6.7.1 ExonanoRNA LLC., Company Information
- 6.7.2 ExonanoRNA LLC., Business Overview
- 6.7.3 ExonanoRNA LLC., Exosome Medical Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 ExonanoRNA LLC., Exosome Medical Technology Product Portfolio
- 6.7.5 ExonanoRNA LLC., Recent Developments
- 6.8 Codiak BioSciences
- 6.8.1 Codiak BioSciences Company Information
- 6.8.2 Codiak BioSciences Business Overview
- 6.8.3 Codiak BioSciences Exosome Medical Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Codiak BioSciences Exosome Medical Technology Product Portfolio
- 6.8.5 Codiak BioSciences Recent Developments
- 6.9 Esperite Group
- 6.9.1 Esperite Group Company Information
- 6.9.2 Esperite Group Business Overview
- 6.9.3 Esperite Group Exosome Medical Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Esperite Group Exosome Medical Technology Product Portfolio
- 6.9.5 Esperite Group Recent Developments
- 6.10 Tavec Pharmaceuticals
- 6.10.1 Tavec Pharmaceuticals Company Information
- 6.10.2 Tavec Pharmaceuticals Business Overview
- 6.10.3 Tavec Pharmaceuticals Exosome Medical Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Tavec Pharmaceuticals Exosome Medical Technology Product Portfolio
- 6.10.5 Tavec Pharmaceuticals Recent Developments
7 North America
- 7.1 North America Exosome Medical Technology Market Size (2021-2032)
- 7.2 North America Exosome Medical Technology Market Size by Type
- 7.2.1 North America Exosome Medical Technology Market Size by Type (2021-2026)
- 7.2.2 North America Exosome Medical Technology Market Size by Type (2027-2032)
- 7.2.3 North America Exosome Medical Technology Market Share by Type (2021-2032)
- 7.3 North America Exosome Medical Technology Market Size by Application
- 7.3.1 North America Exosome Medical Technology Market Size by Application (2021-2026)
- 7.3.2 North America Exosome Medical Technology Market Size by Application (2027-2032)
- 7.3.3 North America Exosome Medical Technology Market Share by Application (2021-2032)
- 7.4 North America Exosome Medical Technology Market Size by Country
- 7.4.1 North America Exosome Medical Technology Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Exosome Medical Technology Market Size by Country (2021-2026)
- 7.4.3 North America Exosome Medical Technology Market Size by Country (2027-2032)
- 7.4.4 North America Exosome Medical Technology Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Exosome Medical Technology Market Size (2021-2032)
- 8.2 Europe Exosome Medical Technology Market Size by Type
- 8.2.1 Europe Exosome Medical Technology Market Size by Type (2021-2026)
- 8.2.2 Europe Exosome Medical Technology Market Size by Type (2027-2032)
- 8.2.3 Europe Exosome Medical Technology Market Share by Type (2021-2032)
- 8.3 Europe Exosome Medical Technology Market Size by Application
- 8.3.1 Europe Exosome Medical Technology Market Size by Application (2021-2026)
- 8.3.2 Europe Exosome Medical Technology Market Size by Application (2027-2032)
- 8.3.3 Europe Exosome Medical Technology Market Share by Application (2021-2032)
- 8.4 Europe Exosome Medical Technology Market Size by Country
- 8.4.1 Europe Exosome Medical Technology Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Exosome Medical Technology Market Size by Country (2021-2026)
- 8.4.3 Europe Exosome Medical Technology Market Size by Country (2027-2032)
- 8.4.4 Europe Exosome Medical Technology Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Exosome Medical Technology Market Size (2021-2032)
- 9.2 China Exosome Medical Technology Market Size by Type
- 9.2.1 China Exosome Medical Technology Market Size by Type (2021-2026)
- 9.2.2 China Exosome Medical Technology Market Size by Type (2027-2032)
- 9.2.3 China Exosome Medical Technology Market Share by Type (2021-2032)
- 9.3 China Exosome Medical Technology Market Size by Application
- 9.3.1 China Exosome Medical Technology Market Size by Application (2021-2026)
- 9.3.2 China Exosome Medical Technology Market Size by Application (2027-2032)
- 9.3.3 China Exosome Medical Technology Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Exosome Medical Technology Market Size (2021-2032)
- 10.2 Asia Exosome Medical Technology Market Size by Type
- 10.2.1 Asia Exosome Medical Technology Market Size by Type (2021-2026)
- 10.2.2 Asia Exosome Medical Technology Market Size by Type (2027-2032)
- 10.2.3 Asia Exosome Medical Technology Market Share by Type (2021-2032)
- 10.3 Asia Exosome Medical Technology Market Size by Application
- 10.3.1 Asia Exosome Medical Technology Market Size by Application (2021-2026)
- 10.3.2 Asia Exosome Medical Technology Market Size by Application (2027-2032)
- 10.3.3 Asia Exosome Medical Technology Market Share by Application (2021-2032)
- 10.4 Asia Exosome Medical Technology Market Size by Country
- 10.4.1 Asia Exosome Medical Technology Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Exosome Medical Technology Market Size by Country (2021-2026)
- 10.4.3 Asia Exosome Medical Technology Market Size by Country (2027-2032)
- 10.4.4 Asia Exosome Medical Technology Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Exosome Medical Technology Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Exosome Medical Technology Market Size by Type
- 11.2.1 South America, Middle East & Africa Exosome Medical Technology Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Exosome Medical Technology Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Exosome Medical Technology Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Exosome Medical Technology Market Size by Application
- 11.3.1 South America, Middle East & Africa Exosome Medical Technology Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Exosome Medical Technology Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Exosome Medical Technology Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Exosome Medical Technology Market Size by Country
- 11.4.1 South America, Middle East & Africa Exosome Medical Technology Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Exosome Medical Technology Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Exosome Medical Technology Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Exosome Medical Technology Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst